![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Corporate information
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Vivo Capital Fund VIII LP | Venture | 2015 | ||
| Vivo Capital Surplus Fund VIII LP | Venture | 2015 |
Funding rounds
Actual initial investment stage
Series A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 4 of 4| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
Blossomhill Therapeutics Inc | Biotechnology company focused on oncology and autoimmune disorders. | Series A Initial investment | |||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Poseida Therapeutics Inc | Series C | ||||
|
|
Poseida Therapeutics Inc | Series B | ||||
|
Tricida Inc | Series C led the round |